0
     

Report Added
Report already added
Celiac Disease Market - Global Outlook and Forecast 2022-2028

Celiac Disease Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Celiac Disease in Global, including the following market information:

Global Celiac Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Celiac Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Distension Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Celiac Disease include Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Celiac Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Celiac Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Celiac Disease Market Segment Percentages, by Type, 2021 (%)
Distension
Diarrhea
Anorexia
Others
Global Celiac Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Celiac Disease Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Celiac Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Celiac Disease Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Celiac Disease revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Celiac Disease revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Celiac Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Celiac Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Celiac Disease Overall Market Size
2.1 Global Celiac Disease Market Size: 2021 VS 2028
2.2 Global Celiac Disease Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Celiac Disease Players in Global Market
3.2 Top Global Celiac Disease Companies Ranked by Revenue
3.3 Global Celiac Disease Revenue by Companies
3.4 Top 3 and Top 5 Celiac Disease Companies in Global Market, by Revenue in 2021
3.5 Global Companies Celiac Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Celiac Disease Players in Global Market
3.6.1 List of Global Tier 1 Celiac Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Celiac Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Celiac Disease Market Size Markets, 2021 & 2028
4.1.2 Distension
4.1.3 Diarrhea
4.1.4 Anorexia
4.1.5 Others
4.2 By Type - Global Celiac Disease Revenue & Forecasts
4.2.1 By Type - Global Celiac Disease Revenue, 2017-2022
4.2.2 By Type - Global Celiac Disease Revenue, 2023-2028
4.2.3 By Type - Global Celiac Disease Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Celiac Disease Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Celiac Disease Revenue & Forecasts
5.2.1 By Application - Global Celiac Disease Revenue, 2017-2022
5.2.2 By Application - Global Celiac Disease Revenue, 2023-2028
5.2.3 By Application - Global Celiac Disease Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Celiac Disease Market Size, 2021 & 2028
6.2 By Region - Global Celiac Disease Revenue & Forecasts
6.2.1 By Region - Global Celiac Disease Revenue, 2017-2022
6.2.2 By Region - Global Celiac Disease Revenue, 2023-2028
6.2.3 By Region - Global Celiac Disease Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Celiac Disease Revenue, 2017-2028
6.3.2 US Celiac Disease Market Size, 2017-2028
6.3.3 Canada Celiac Disease Market Size, 2017-2028
6.3.4 Mexico Celiac Disease Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Celiac Disease Revenue, 2017-2028
6.4.2 Germany Celiac Disease Market Size, 2017-2028
6.4.3 France Celiac Disease Market Size, 2017-2028
6.4.4 U.K. Celiac Disease Market Size, 2017-2028
6.4.5 Italy Celiac Disease Market Size, 2017-2028
6.4.6 Russia Celiac Disease Market Size, 2017-2028
6.4.7 Nordic Countries Celiac Disease Market Size, 2017-2028
6.4.8 Benelux Celiac Disease Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Celiac Disease Revenue, 2017-2028
6.5.2 China Celiac Disease Market Size, 2017-2028
6.5.3 Japan Celiac Disease Market Size, 2017-2028
6.5.4 South Korea Celiac Disease Market Size, 2017-2028
6.5.5 Southeast Asia Celiac Disease Market Size, 2017-2028
6.5.6 India Celiac Disease Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Celiac Disease Revenue, 2017-2028
6.6.2 Brazil Celiac Disease Market Size, 2017-2028
6.6.3 Argentina Celiac Disease Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Celiac Disease Revenue, 2017-2028
6.7.2 Turkey Celiac Disease Market Size, 2017-2028
6.7.3 Israel Celiac Disease Market Size, 2017-2028
6.7.4 Saudi Arabia Celiac Disease Market Size, 2017-2028
6.7.5 UAE Celiac Disease Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Celiac Disease Major Product Offerings
7.1.4 Roche Celiac Disease Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Celiac Disease Major Product Offerings
7.2.4 Merck Celiac Disease Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Celiac Disease Major Product Offerings
7.3.4 Johnson & Johnson Celiac Disease Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 BiolineRx
7.4.1 BiolineRx Corporate Summary
7.4.2 BiolineRx Business Overview
7.4.3 BiolineRx Celiac Disease Major Product Offerings
7.4.4 BiolineRx Celiac Disease Revenue in Global Market (2017-2022)
7.4.5 BiolineRx Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Celiac Disease Major Product Offerings
7.5.4 Pfizer Celiac Disease Revenue in Global Market (2017-2022)
7.5.5 Pfizer Key News
7.6 Innovate Biopharmaceuticals
7.6.1 Innovate Biopharmaceuticals Corporate Summary
7.6.2 Innovate Biopharmaceuticals Business Overview
7.6.3 Innovate Biopharmaceuticals Celiac Disease Major Product Offerings
7.6.4 Innovate Biopharmaceuticals Celiac Disease Revenue in Global Market (2017-2022)
7.6.5 Innovate Biopharmaceuticals Key News
7.7 ImmusanT
7.7.1 ImmusanT Corporate Summary
7.7.2 ImmusanT Business Overview
7.7.3 ImmusanT Celiac Disease Major Product Offerings
7.7.4 ImmusanT Celiac Disease Revenue in Global Market (2017-2022)
7.7.5 ImmusanT Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Celiac Disease Major Product Offerings
7.8.4 Novartis Celiac Disease Revenue in Global Market (2017-2022)
7.8.5 Novartis Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Celiac Disease Major Product Offerings
7.9.4 Bristol-Myers Squibb Celiac Disease Revenue in Global Market (2017-2022)
7.9.5 Bristol-Myers Squibb Key News
7.10 Immunomedics
7.10.1 Immunomedics Corporate Summary
7.10.2 Immunomedics Business Overview
7.10.3 Immunomedics Celiac Disease Major Product Offerings
7.10.4 Immunomedics Celiac Disease Revenue in Global Market (2017-2022)
7.10.5 Immunomedics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Celiac Disease Market Opportunities & Trends in Global Market
Table 2. Celiac Disease Market Drivers in Global Market
Table 3. Celiac Disease Market Restraints in Global Market
Table 4. Key Players of Celiac Disease in Global Market
Table 5. Top Celiac Disease Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Celiac Disease Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Celiac Disease Revenue Share by Companies, 2017-2022
Table 8. Global Companies Celiac Disease Product Type
Table 9. List of Global Tier 1 Celiac Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Celiac Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Celiac Disease Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Celiac Disease Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Celiac Disease Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Celiac Disease Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Celiac Disease Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Celiac Disease Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Celiac Disease Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Celiac Disease Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Celiac Disease Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Celiac Disease Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Celiac Disease Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Celiac Disease Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Celiac Disease Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Celiac Disease Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Celiac Disease Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Celiac Disease Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Celiac Disease Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Celiac Disease Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Celiac Disease Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Celiac Disease Product Offerings
Table 32. Roche Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Celiac Disease Product Offerings
Table 35. Merck Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Celiac Disease Product Offerings
Table 38. Johnson & Johnson Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 39. BiolineRx Corporate Summary
Table 40. BiolineRx Celiac Disease Product Offerings
Table 41. BiolineRx Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Celiac Disease Product Offerings
Table 44. Pfizer Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 45. Innovate Biopharmaceuticals Corporate Summary
Table 46. Innovate Biopharmaceuticals Celiac Disease Product Offerings
Table 47. Innovate Biopharmaceuticals Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 48. ImmusanT Corporate Summary
Table 49. ImmusanT Celiac Disease Product Offerings
Table 50. ImmusanT Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Celiac Disease Product Offerings
Table 53. Novartis Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Celiac Disease Product Offerings
Table 56. Bristol-Myers Squibb Celiac Disease Revenue (US$, Mn), (2017-2022)
Table 57. Immunomedics Corporate Summary
Table 58. Immunomedics Celiac Disease Product Offerings
Table 59. Immunomedics Celiac Disease Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Celiac Disease Segment by Type in 2021
Figure 2. Celiac Disease Segment by Application in 2021
Figure 3. Global Celiac Disease Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Celiac Disease Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Celiac Disease Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Celiac Disease Revenue in 2021
Figure 8. By Type - Global Celiac Disease Revenue Market Share, 2017-2028
Figure 9. By Application - Global Celiac Disease Revenue Market Share, 2017-2028
Figure 10. By Region - Global Celiac Disease Revenue Market Share, 2017-2028
Figure 11. By Country - North America Celiac Disease Revenue Market Share, 2017-2028
Figure 12. US Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Celiac Disease Revenue Market Share, 2017-2028
Figure 16. Germany Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 17. France Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Celiac Disease Revenue Market Share, 2017-2028
Figure 24. China Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 28. India Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Celiac Disease Revenue Market Share, 2017-2028
Figure 30. Brazil Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Celiac Disease Revenue Market Share, 2017-2028
Figure 33. Turkey Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Celiac Disease Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BiolineRx Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Innovate Biopharmaceuticals Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ImmusanT Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Immunomedics Celiac Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Celiac Disease Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single Use Equipment, Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Biopharma, CMOs), Region - Global Forecast to 2027

Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single Use Equipment, Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Biopharma, CMOs), Region - Global Forecast to 2027

Theranos Scandal - Silicon Valley Scandal Indicative of the Current Investment Culture

Theranos Scandal - Silicon Valley Scandal Indicative of the Current Investment Culture